1. Home
  2. MDWD vs ATNI Comparison

MDWD vs ATNI Comparison

Compare MDWD & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • ATNI
  • Stock Information
  • Founded
  • MDWD 2000
  • ATNI 1987
  • Country
  • MDWD Israel
  • ATNI United States
  • Employees
  • MDWD N/A
  • ATNI N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • ATNI Telecommunications Equipment
  • Sector
  • MDWD Health Care
  • ATNI Telecommunications
  • Exchange
  • MDWD Nasdaq
  • ATNI Nasdaq
  • Market Cap
  • MDWD 230.6M
  • ATNI 240.0M
  • IPO Year
  • MDWD 2014
  • ATNI 1991
  • Fundamental
  • Price
  • MDWD $19.09
  • ATNI $15.26
  • Analyst Decision
  • MDWD Strong Buy
  • ATNI Strong Buy
  • Analyst Count
  • MDWD 2
  • ATNI 1
  • Target Price
  • MDWD $35.00
  • ATNI $30.00
  • AVG Volume (30 Days)
  • MDWD 59.0K
  • ATNI 45.7K
  • Earning Date
  • MDWD 08-13-2025
  • ATNI 07-23-2025
  • Dividend Yield
  • MDWD N/A
  • ATNI 6.29%
  • EPS Growth
  • MDWD N/A
  • ATNI N/A
  • EPS
  • MDWD N/A
  • ATNI N/A
  • Revenue
  • MDWD $19,213,000.00
  • ATNI $721,575,000.00
  • Revenue This Year
  • MDWD $20.80
  • ATNI $2.03
  • Revenue Next Year
  • MDWD $26.92
  • ATNI $1.59
  • P/E Ratio
  • MDWD N/A
  • ATNI N/A
  • Revenue Growth
  • MDWD N/A
  • ATNI N/A
  • 52 Week Low
  • MDWD $12.78
  • ATNI $13.76
  • 52 Week High
  • MDWD $24.00
  • ATNI $33.72
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 37.96
  • ATNI 45.12
  • Support Level
  • MDWD $19.98
  • ATNI $15.22
  • Resistance Level
  • MDWD $20.95
  • ATNI $16.11
  • Average True Range (ATR)
  • MDWD 0.64
  • ATNI 0.52
  • MACD
  • MDWD -0.38
  • ATNI 0.06
  • Stochastic Oscillator
  • MDWD 0.29
  • ATNI 46.98

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About ATNI ATN International Inc.

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.

Share on Social Networks: